药物对比
Bexagliflozin vs Tolazamide
比较 Bexagliflozin 与 Tolazamide 治疗2型糖尿病。SGLT2抑制剂 vs 磺脲类：作用机制、低血糖风险、体重、心血管获益及副作用。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients considering a switch from an older sulfonylurea to a newer SGLT2 inhibitor due to hypoglycemia, weight, or organ protection concerns.
结论
Bexagliflozin generally provides a more favorable efficacy and safety profile than Tolazamide for most type 2 diabetes patients.
全部药物对比